Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
gptkb:insulin |
| gptkbp:activeIngredient |
gptkb:insulin
|
| gptkbp:approvalYear |
2015
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
A10AE04
|
| gptkbp:biosimilar |
gptkb:Lantus
|
| gptkbp:form |
solution for injection
|
| gptkbp:halfLife |
~24 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Basaglar
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Eli_Lilly_and_Company
|
| gptkbp:marketedAs |
gptkb:Basaglar_Cartridge
gptkb:Basaglar_KwikPen |
| gptkbp:packaging |
cartridge
pre-filled pen |
| gptkbp:powers |
100 units/mL
|
| gptkbp:pregnancyCategory |
Category C (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
subcutaneous injection
|
| gptkbp:sideEffect |
gptkb:hypoglycemia
allergic reactions injection site reactions |
| gptkbp:storage |
2-8°C (refrigerated)
|
| gptkbp:usedFor |
gptkb:type_2_diabetes
type 1 diabetes |
| gptkbp:bfsParent |
gptkb:insulin
gptkb:Lantus |
| gptkbp:bfsLayer |
6
|